Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

NCT04695704 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
86
Enrollment
OTHER
Sponsor class

Stopped The incidence of respiratory Long COVID has decreased in the new waves, thus made impossible to achieve the required study sample.

Conditions

Interventions

Sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Collaborators